StockData
Ocular Therapeutix, Inc logo

Ocular Therapeutix, Inc (OCUL) stock

OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$6.02+0.01 (+0.17%)

Close on Nov 17, 2026Market cap $1.32BP/E –Yield –

Ocular Therapeutix enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Ocular Therapeutix's enterprise value was $936.62M on Nov 11, 2026, against $1.85B a year earlier. Over the last 5 years it ranged from $119.90M to $1.85B, with a median of $831.09M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$936.62M-49.4%
2025Dec 31, 2025$1.85B+89.1%
2024Dec 31, 2024$978.43M+216.9%
2023Dec 29, 2023$308.75M+155.9%
2022Dec 30, 2022$120.64M-68.2%
2021Dec 31, 2021$379.61M-69.7%
2020Dec 31, 2020$1.25B+739.0%
2019Dec 31, 2019$149.45M+32.8%
2018Dec 31, 2018$112.50M+20.3%
2017Dec 29, 2017$93.54M-35.2%
2016Dec 30, 2016$144.28M+13.3%
2015Dec 31, 2015$127.33M-70.8%
2014Dec 31, 2014$435.39M–

More Ocular Therapeutix figures

See a number that looks wrong?